Tags |
|
|
Links |
|
|
Main Subject - Synchronize Six Sigma Into Your Business
The foundation for success of Six Sigma is laid by synchronizing Six Sigma into the way business is carried out. There is no dispute about the need for synchronizing the met
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
hodology with the business if it has to succeed in transforming the enterprise.
Why Synchronize Six Sigma Into Your Business?
What leadership must keep in mind when decidi
Why Synchronize Six Sigma Into Your Business?
What leadership must keep in mind when decidi
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ng on Six Sigma is its ability to solve the most difficult problems. However, commoditization and variability in deployment have been the stumbling blocks for success. ‘Dumb
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ing Down’ of the methodology and displacing it as a tool of decision making which is aided by the critical thinking process and losing customer focus will only contribute to
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
the acceleration of its demise. If things are not put into proper perspective, the metrics for its goal measurement, which is maximization of bottom line or savings, loses f
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ocus.
Phases In Synchronizing Six Sigma
Six Sigma can be synchronized with business processes in three phases. The phases can be modified based on the suitability.
Initia
Phases In Synchronizing Six Sigma
Six Sigma can be synchronized with business processes in three phases. The phases can be modified based on the suitability.
Initia
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
lization Phase: The various steps can be summarized as follows:
1. Identifying and apportioning of enterprise level savings goal with SBUs
2. Identifying Champions and ali
1. Identifying and apportioning of enterprise level savings goal with SBUs
2. Identifying Champions and ali
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ning compensations to attainment of goals
3. Establishment and streamlining of the steering committee and reporting channels
4. Writing down and aligning the deployment pl
3. Establishment and streamlining of the steering committee and reporting channels
4. Writing down and aligning the deployment pl
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
an with a highlighted financial savings plan
5. Communicating and preparing the workforce to deployment
Execution Phase: This is the crucial phase in the implementation. T
5. Communicating and preparing the workforce to deployment
Execution Phase: This is the crucial phase in the implementation. T
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
he project progress decides the direction in which it is moving.
1. All key data are communicated, through a designated database, to upper management for continuous review
1. All key data are communicated, through a designated database, to upper management for continuous review
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
2. Champions engage X-belts to gauge progress to ensure mentoring
3. Regular monitoring and reviews at business meetings
4. Delays are discussed and dealt with according t
3. Regular monitoring and reviews at business meetings
4. Delays are discussed and dealt with according t
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
o necessities. They are terminated, postponed or extended with additional resources as may become necessary.
5. Steering committees at SBU and corporate levels assess progr
5. Steering committees at SBU and corporate levels assess progr
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ess towards stated goals and day to day benefits and prioritize new projects for assignment to the Belts
6. Project teams are individually acknowledged for their accomplish
6. Project teams are individually acknowledged for their accomplish
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ments and rewarded
7. X-belts prepare document of implementation as knowledge notes for records and future references
8. Champions report to accountable executives in the
7. X-belts prepare document of implementation as knowledge notes for records and future references
8. Champions report to accountable executives in the
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
anagement
Assessment Phase: Assessment is done at least once a year to assess the progress and quantify the figures.
1. Promotes greater and earlier alignment by accelerat
Assessment Phase: Assessment is done at least once a year to assess the progress and quantify the figures.
1. Promotes greater and earlier alignment by accelerat
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ing result generation and sustainability
2. Emphasis is placed on real versus theoretical or anecdotal data
3. Focus will be placed on capturing benefits, enhancing the be
2. Emphasis is placed on real versus theoretical or anecdotal data
3. Focus will be placed on capturing benefits, enhancing the be
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
lts’ performance and certification, deployment planning,
and overall performance
4. SBUs are informed of results relative to the organization.
5. Steering committees rev
4. SBUs are informed of results relative to the organization.
5. Steering committees rev
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
sit the deployment plan with a view to revise as may be necessary
6. Training for Belts or refresher workshops, and reorientation for Master Black Belts and Champions who u
6. Training for Belts or refresher workshops, and reorientation for Master Black Belts and Champions who u
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ndergo certification program are scheduled
7. Rescheduling, if necessary, of early sustainability by “training the trainer”
Like implementation, synchronization is a conti
7. Rescheduling, if necessary, of early sustainability by “training the trainer”
Like implementation, synchronization is a conti
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
nuous process as seen above until self- sustainability and goals are achieved. Benefits can be realized with perseverance by all those involved throughout its implementation
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/22794/mainsubjects-Synchronize-Six-Sigma-Into-Your-Business.html">Synchronize Six Sigma Into Your Business</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/22794/mainsubjects-Synchronize-Six-Sigma-Into-Your-Business.html]Synchronize Six Sigma Into Your Business[/url]
Related Articles:
Creating a Powerful Project Vision
Setting Up A Corporation In Idaho
Bookmark it:
|